Nuvo Pharmaceuticals Inc (MRVFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 22,199 | 18,759 | 17,772 | 15,846 | 12,379 |
| Receivables | 7,071 | 6,667 | 5,590 | 7,461 | 8,945 |
| Inventories | 7,133 | 7,920 | 7,084 | 6,461 | 6,359 |
| Other current assets | 2,066 | 1,776 | 2,202 | 2,115 | 2,346 |
| TOTAL | $38,470 | $35,122 | $32,648 | $31,883 | $30,029 |
| Non-Current Assets | |||||
| PPE Net | 2,707 | 2,726 | 2,596 | 2,367 | 2,411 |
| Intangibles | 78,272 | 77,637 | 75,345 | 80,250 | 79,139 |
| Other Non-Current Assets | 2,733 | 2,766 | 2,703 | 2,722 | 2,651 |
| TOTAL | $83,711 | $83,130 | $80,644 | $85,339 | $84,201 |
| Total Assets | $122,181 | $118,252 | $113,293 | $117,222 | $114,230 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 9,556 | 9,407 | 9,210 | 4,761 | 4,739 |
| Accounts payable and accrued liabilities | 8,201 | 7,642 | 6,206 | 5,384 | 5,043 |
| Other current liabilities | 375 | 339 | 296 | 229 | 501 |
| TOTAL | $18,776 | $17,862 | $16,241 | $11,271 | $11,230 |
| Non-Current Liabilities | |||||
| Long Term Debt | 69,668 | 69,869 | 68,200 | 78,912 | 79,078 |
| Other Non-Current Liabilities | 22,562 | 27,904 | 13,428 | 12,924 | 8,709 |
| TOTAL | $93,597 | $98,235 | $81,852 | $92,061 | $88,002 |
| Total Liabilities | $112,373 | $116,097 | $98,092 | $103,332 | $99,232 |
| Shareholders' Equity | |||||
| Common Shares | 150,435 | 145,927 | 137,926 | 138,702 | 133,307 |
| Retained earnings | -154,237 | -156,839 | -134,812 | -137,400 | -130,012 |
| Other shareholders' equity | 342 | 231 | 28 | 502 | 123 |
| TOTAL | $9,808 | $2,155 | $15,200 | $13,890 | $14,998 |
| Total Liabilities And Equity | $122,181 | $118,252 | $113,293 | $117,222 | $114,230 |